Human Absorption, Distribution, Metabolism, and Excretion Study of [14C]Adavosertib

Trial Identifier: D601HC00004
Sponsor: AstraZeneca
Collaborator:
Parexel
NCTID:: NCT05008913
Start Date: October 2021
Primary Completion Date: October 2021
Study Completion Date: November 2021
Condition: Cancer - Other

Available Languages

For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.

Language Description
English Version

Trial Locations

Country Location
GB London, GB, W12 0HS
GB Manchester, GB, M20 4BX
GB Wirral, GB, CH63 4JY